🔎 Trials Near Me

Beranda › Penyakit Paru Interstisial › South Carolina › Charleston

Uji klinis Penyakit Paru Interstisial di Charleston, SC

13 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi sekitar Charleston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Menerima pesertaFase 3
  • Lowcountry Lung and Critical Care, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Menerima pesertaFase 3
  • Medical University of South Carolina, Charleston
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Menerima pesertaFase 2
  • MUSC, Charleston
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05798923

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Menerima peserta
  • Medical University of South Carolina, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07269262

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Menerima pesertaFase 2
  • Medical University of South Carolina, Charleston
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Menerima pesertaFase 2
  • Clinical Research Site, Charleston
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Menerima peserta
  • Medical University of South Carolina, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Menerima pesertaStudi observasional
  • Medical University of South Carolina, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

Menerima pesertaFase 2
  • Medical University of South Carolina (MUSC), Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Menerima pesertaStudi observasional
  • Medical University of South Carolina, Charleston
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Menerima pesertaFase 3
  • Medical University of South Carolina-Nexus, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Menerima pesertaStudi observasional
  • Medical University of South Carolina, Charleston
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT06129240

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Menerima pesertaFase 2
  • aTyr Investigative Site, Charleston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2025 · NCT05892614

Uji klinis Penyakit Paru Interstisial di kota lain

Studi lain di Charleston

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.